“…This disease is strongly associated with atherosclerosis and metabolic syndrome [3], and its pharmacological treatment is limited, being cholecystectomy, an invasive surgical treatment, the only treatment for symptomatic gallstones [4]. Cholesterol gallstones formation is a complex process mediated by genetic and environmental factors [5, 6]. Many proteins (ATP-binding cassette (ABC)) are implicated in its formation, mainly the biliary lipids transporters ABCB4, ABCB11, ABCG5, ABCG8, ABCC7, and Niemann-Pick C1L1 protein, and these transporters are regulated in the liver by several transcription factors, including nuclear receptors farnesoid X receptor and liver X receptors [7–9].…”